On the role of surrogates in the efficient estimation of treatment
  effects with limited outcome data
  We study the problem of estimating treatment effects when the outcome of
primary interest (e.g., long-term health status) is only seldom observed but
abundant surrogate observations (e.g., short-term health outcomes) are
available. To investigate the role of surrogates in this setting, we derive the
semiparametric efficiency lower bounds of average treatment effect (ATE) both
with and without presence of surrogates, as well as several intermediary
settings. These bounds characterize the best-possible precision of ATE
estimation in each case, and their difference quantifies the efficiency gains
from optimally leveraging the surrogates in terms of key problem
characteristics when only limited outcome data are available. We show these
results apply in two important regimes: when the number of surrogate
observations is comparable to primary-outcome observations and when the former
dominates the latter. Importantly, we take a missing-data approach that
circumvents strong surrogate conditions which are commonly assumed in previous
literature but almost always fail in practice. To show how to leverage the
efficiency gains of surrogate observations, we propose ATE estimators and
inferential methods based on flexible machine learning methods to estimate
nuisance parameters that appear in the influence functions. We show our
estimators enjoy efficiency and robustness guarantees under weak conditions.
